Foamix Pharmaceuticals Ltd. Debt Issuance Costs, Net
Foamix Pharmaceuticals Ltd. had Debt Issuance Costs, Net of $1.09 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Debt › Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
us-gaap:DeferredFinanceCostsNet · last filed 2020-03-12
- 2019-12-31: Debt Issuance Costs, Net $1.09M.
- 2019-09-30: Debt Issuance Costs, Net $1.09M.
| Period end | Debt Issuance Costs, Net |
|---|---|
| 2019-12-31 | $1.09M 10-K · filed 2020-03-12 |
| 2019-09-30 | $1.09M 10-Q · filed 2019-11-12 |